Drug repurposing to overcome resistance to various therapies for colorectal cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug repurposing to overcome resistance to various therapies for colorectal cancer
Authors
Keywords
Cetuximab, 5-Fluorouracil, Immunotherapy, Irinotecan, Molecular targeted chemotherapy, Pembrolizumab
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-14
DOI
10.1007/s00018-019-03134-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer
- (2018) Emerson Y. Chen et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial
- (2018) Susen Burock et al. BMC CANCER
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Combined blockade of IL-6 and PD-1/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment
- (2018) Hirotake Tsukamoto et al. CANCER RESEARCH
- The poor design of clinical trials of statins in oncology may explain their failure – Lessons for drug repurposing
- (2018) Marwan I. Abdullah et al. CANCER TREATMENT REVIEWS
- Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
- (2018) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
- (2018) Shang Yao et al. SEMINARS IN CANCER BIOLOGY
- Taking advantage of drug resistance, a new approach in the war on cancer
- (2018) Liqin Wang et al. Frontiers of Medicine
- Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
- (2018) Muhammad Zubair Afzal et al. Journal for ImmunoTherapy of Cancer
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Study Protocol: Phase-Ib Trial of Nivolumab Combined With Metformin for Refractory/Recurrent Solid Tumors
- (2018) Toshio Kubo et al. Clinical Lung Cancer
- Final results of a phase II of metformin plus irinotecan for refractory colorectal cancer.
- (2018) Arinilda Bragagnoli et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
- (2018) Jong-Ho Cha et al. MOLECULAR CELL
- Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy
- (2018) Guozhu Xie et al. Journal for ImmunoTherapy of Cancer
- Exosome–transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression
- (2018) Rui Zheng et al. Molecular Cancer
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
- (2017) Yuji Miyamoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival
- (2017) Xinwei Hua et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status
- (2017) Tsuyoshi Hamada et al. JOURNAL OF CLINICAL ONCOLOGY
- Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
- (2017) Yuanyuan Lu et al. NATURE MEDICINE
- Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
- (2017) Matthias Pinter et al. Science Translational Medicine
- Present and future of metastatic colorectal cancer treatment: A review of new candidate targets
- (2017) Giulia Martini et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
- (2017) Lingyi Shi et al. OncoTargets and Therapy
- Function of insulin‑like growth factor 1 receptor in cancer resistance to chemotherapy (Review)
- (2017) Jingsheng Yuan et al. Oncology Letters
- Autophagy activation promotes bevacizumab resistance in glioblastoma by suppressing Akt/mTOR signaling pathway
- (2017) He Huang et al. Oncology Letters
- Metformin increases chemo-sensitivity via gene downregulation encoding DNA replication proteins in 5-Fu resistant colorectal cancer cells
- (2017) Sung-Hee Kim et al. Oncotarget
- The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-β-catenin signaling axis
- (2017) Araceli Valverde et al. Oncotarget
- Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells
- (2017) Paul E. Clavijo et al. Oncotarget
- Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3
- (2017) Sung Yong Ahn et al. Oncotarget
- Zoledronic Acid Regulates Autophagy and Induces Apoptosis in Colon Cancer Cell Line CT26
- (2017) Jinhua Zhu et al. Biomed Research International
- Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
- (2017) J. Javier Hernandez et al. Frontiers in Oncology
- Oncolytic Virus-Mediated Targeting of PGE 2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy
- (2016) Weizhou Hou et al. CANCER CELL
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer
- (2016) Vanessa C. Miranda et al. Clinical Colorectal Cancer
- PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies
- (2016) L. Paleari et al. CLINICAL ONCOLOGY
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Novel anti-angiogenic therapeutic strategies in colorectal cancer
- (2016) M. Tampellini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway
- (2016) Malte B. Monin et al. JOURNAL OF SURGICAL RESEARCH
- Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)
- (2016) P. P. Singh et al. ONCOLOGIST
- Mechanisms of drug resistance in colon cancer and its therapeutic strategies
- (2016) Tao Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer
- (2016) Vincenzo Sforza et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Synergistic Effects of Simvastatin and Irinotecan against Colon Cancer Cells with or without Irinotecan Resistance
- (2016) Hyun Joo Jang et al. Gastroenterology Research and Practice
- Statin induces apoptosis of human colon cancer cells and downregulation of insulin-like growth factor 1 receptor via proapoptotic ERK activation
- (2016) HYUN JOO JANG et al. Oncology Letters
- Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells
- (2016) Yang Lu et al. Oncotarget
- Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
- (2016) Ben Zhao et al. Oncotarget
- Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
- (2016) Nicole E. Scharping et al. Cancer Immunology Research
- Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
- (2015) Muhammad Zaeem Noman et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Safety and efficacy of the addition of simvastatin to panitumumab in previously treated KRAS mutant metastatic colorectal cancer patients
- (2015) Jara M. Baas et al. ANTI-CANCER DRUGS
- A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
- (2015) S H Lim et al. BRITISH JOURNAL OF CANCER
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless ofKRASstatus
- (2015) Junko Kato et al. INTERNATIONAL JOURNAL OF CANCER
- Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients
- (2015) J. M. Baas et al. INVESTIGATIONAL NEW DRUGS
- Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer
- (2015) Chandan Rana et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Immune-mediated antitumor effect by type 2 diabetes drug, metformin
- (2015) Shingo Eikawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacologic resistance in colorectal cancer: a review
- (2015) William A. Hammond et al. Therapeutic Advances in Medical Oncology
- Inhibition of COX-2 in Colon Cancer Modulates Tumor Growth and MDR-1 Expression to Enhance Tumor Regression in Therapy-Refractory Cancers In Vivo
- (2015) Mahbuba Rahman et al. NEOPLASIA
- Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity
- (2014) Nelson Ung et al. CANCER BIOLOGY & THERAPY
- Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab
- (2014) Jeeyun Lee et al. INVESTIGATIONAL NEW DRUGS
- Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies
- (2014) Simonetta M. Leto et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer
- (2014) Kimmie Ng et al. JNCI-Journal of the National Cancer Institute
- Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer
- (2014) Pratima Nangia-Makker et al. PLoS One
- Statin Use Is Not Associated with Improved Progression Free Survival in Cetuximab Treated KRAS Mutant Metastatic Colorectal Cancer Patients: Results from the CAIRO2 Study
- (2014) Lisanne L. Krens et al. PLoS One
- Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) R. Labianca et al. ANNALS OF ONCOLOGY
- Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells
- (2013) P Liu et al. BRITISH JOURNAL OF CANCER
- The Invisible Arm of Immunity in Common Cancer Chemoprevention Agents
- (2013) E. Marzbani et al. Cancer Prevention Research
- Autophagy Inhibition Sensitizes Colon Cancer Cells to Antiangiogenic and Cytotoxic Therapy
- (2013) M. Selvakumaran et al. CLINICAL CANCER RESEARCH
- Nonsteroidal anti-inflammatory drugs suppress cancer stem cellsviainhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer
- (2013) Chang Mo Moon et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
- (2013) Enric Domingo et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump
- (2013) T. Mazard et al. MOLECULAR CANCER THERAPEUTICS
- Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer
- (2013) R. Li et al. MOLECULAR CANCER THERAPEUTICS
- Combined 5-FU and ChoKα Inhibitors as a New Alternative Therapy of Colorectal Cancer: Evidence in Human Tumor-Derived Cell Lines and Mouse Xenografts
- (2013) Ana de la Cueva et al. PLoS One
- Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
- (2013) Yanfei Zhang et al. PLoS One
- Metformin use and improved response to therapy in rectal cancer
- (2013) Heath D. Skinner et al. Cancer Medicine
- Resistance of colon cancer to 5-fluorouracil may be overcome by combination with chloroquine, an in vivo study
- (2012) Kazuhito Sasaki et al. ANTI-CANCER DRUGS
- Hypoxia-Induced Autophagy Promotes Tumor Cell Survival and Adaptation to Antiangiogenic Treatment in Glioblastoma
- (2012) Y.-L. Hu et al. CANCER RESEARCH
- PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP-binding Cassette C10) transporter
- (2012) Jun-Jiang Chen et al. CANCER SCIENCE
- Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
- (2012) M. Sen et al. CLINICAL CANCER RESEARCH
- Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
- (2012) Farhat V.N. Din et al. GASTROENTEROLOGY
- Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
- (2012) Weijing Sun Journal of Hematology & Oncology
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Blockade of the EGFR and COX-2 Pathways
- (2011) Emily Chan et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Statins are logical candidates for overcoming limitations of targeting therapies on malignancy: their potential application to gastrointestinal cancers
- (2011) Shouji Shimoyama CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Sildenafil Reverses ABCB1- and ABCG2-Mediated Chemotherapeutic Drug Resistance
- (2011) Z. Shi et al. CANCER RESEARCH
- Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations
- (2011) T. Osada et al. CANCER RESEARCH
- COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps
- (2011) Y. Nakanishi et al. CARCINOGENESIS
- The controversial role of ABC transporters in clinical oncology
- (2011) Akina Tamaki et al. Essays in Biochemistry
- Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway
- (2011) L. L. Kodach et al. GUT
- Relationship Between Statin Use and Colon Cancer Recurrence and Survival: Results From CALGB 89803
- (2011) K. Ng et al. JNCI-Journal of the National Cancer Institute
- Effect of Simvastatin on Cetuximab Resistance in Human Colorectal Cancer With KRAS Mutations
- (2011) Jeeyun Lee et al. JNCI-Journal of the National Cancer Institute
- Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma
- (2011) James A. Bonner et al. RADIOTHERAPY AND ONCOLOGY
- Roles of autophagy in cetuximab-mediated cancer therapy against EGFR
- (2010) Xinqun Li et al. Autophagy
- Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells
- (2010) Kazuhito Sasaki et al. BMC CANCER
- A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
- (2010) Andrey Loboda et al. BMC Medical Genomics
- The Epidermal Growth Factor Receptor Antibody Cetuximab Induces Autophagy in Cancer Cells by Downregulating HIF-1 and Bcl-2 and Activating the Beclin 1/hVps34 Complex
- (2010) X. Li et al. CANCER RESEARCH
- Therapeutic modulation of k-ras signaling in colorectal cancer
- (2010) Lisanne L. Krens et al. DRUG DISCOVERY TODAY
- 5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer
- (2010) Rodrigo Jover et al. GASTROENTEROLOGY
- Differential interactions between statins and P-glycoprotein: Implications for exploiting statins as anticancer agents
- (2010) Carolyn A. Goard et al. INTERNATIONAL JOURNAL OF CANCER
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines
- (2009) Xiaoxia Guo et al. CANCER LETTERS
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
- (2009) A. Greenhough et al. CARCINOGENESIS
- The role of COX-2 in intestinal inflammation and colorectal cancer
- (2009) D Wang et al. ONCOGENE
- Mutant B-RAF mediates resistance to anoikis via Bad and Bim
- (2008) K Boisvert-Adamo et al. ONCOGENE
- Targeting the epidermal growth factor receptor in metastatic colorectal cancer
- (2007) Kimmie Ng et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started